Cerenome, Inc. (CNSY) shareholders
Close on Nov 17, 2026Market cap $4.78MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Highbridge Capital Management, LLC | 13,157,894 | 7.10% | 13G (passive) | Mar 31, 2026 |
| Heights Capital Management, Inc. Joint filing with CVI Investments, Inc. (6.90%) | 12,368,423 | 6.90% | 13G (passive) | Jan 14, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CNSY | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 304,745 | 4.02% | $1.33M | +207,661 | 0.00% |
| BlackRock, Inc. | 95,983 | 1.26% | $419.45K | +24,928 | 0.00% |
| Geode Capital Management, LLC | 76,155 | 1.00% | $332.94K | −4,497 | 0.00% |
| Vanguard Fiduciary Trust Co | 36,868 | 0.49% | $161.11K | −9,683 | 0.00% |
| Ashton Thomas Private Wealth, LLC | 34,306 | 0.45% | $149.92K | +32,989 | 0.00% |
| Citadel Advisors LLC | 25,597 | 0.34% | $111.86K | New | 0.00% |
| Northern Trust Corp | 15,516 | 0.20% | $67.81K | +3,784 | 0.00% |
| Virtu Financial LLC | 15,343 | 0.20% | $67.00K | New | 0.00% |
| Hrt Financial LP | 11,612 | 0.15% | $50.00K | New | 0.00% |
| Wells Fargo & Company/Mn | 6,156 | 0.08% | $26.90K | +6,154 | 0.00% |
| Vanguard Global Advisers, LLC | 2,282 | 0.03% | $9.97K | −1 | 0.00% |
| Osaic Holdings, Inc. | 2,000 | 0.03% | $8.74K | +1,995 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,955 | 0.03% | $8.54K | New | 0.00% |
| Allied Private Wealth LLC | 496 | 0.01% | $1.89K | New | 0.00% |
| UBS Group AG | 470 | 0.01% | $2.05K | −3,044 | 0.00% |
| SBI Securities Co., Ltd. | 251 | 0.00% | $1.10K | +145 | 0.00% |
| Morgan Stanley | 185 | 0.00% | $808 | New | 0.00% |
| Barclays PLC | 96 | 0.00% | $420 | +96 | 0.00% |
| Citigroup Inc | 17 | 0.00% | $74 | −3,703 | 0.00% |
| Caitong International Asset Management Co., Ltd | 12 | 0.00% | $52 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 21 | 1M | 8.3% | 8 / 8 | 5 / 12 | 0M | 0M |
| Q1 2026 | 25 | 0M | 4.8% | 7 / 5 | 2 / 8 | 0M | 0M |
| Q4 2025 | 27 | 0M | 6.1% | 11 / 9 | 1 / 6 | 0M | 0M |
| Q3 2025 | 23 | 0M | 2.7% | 11 / 7 | 3 / 7 | 0M | 0M |
| Q2 2025 | 19 | 0M | 0.2% | 8 / 3 | 4 / 6 | 0M | 0M |
| Q1 2025 | 17 | 0M | 0.2% | 7 / 2 | 2 / 1 | 0M | 0M |
| Q4 2024 | 11 | 0M | 0.4% | 2 / 2 | 0 / 2 | 0M | 0M |
| Q3 2024 | 11 | 0M | 0.4% | 2 / 2 | 2 / 2 | 0M | 0M |
| Q2 2024 | 12 | 0M | 0.4% | 4 / 3 | 0 / 2 | 0M | 0M |
| Q1 2024 | 10 | 0M | 0.1% | 0 / 2 | 2 / 2 | 0M | 0M |
| Q4 2023 | 12 | 0M | 0.1% | 3 / 3 | 1 / 3 | 0M | 0M |
| Q3 2023 | 12 | 0M | 0.0% | 5 / 1 | 2 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
10 funds held CNSY in Q2 2026, 83% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CNSY | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 203,500 | 2.68% | $889.30K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 86,245 | 1.14% | $376.89K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 39,144 | 0.52% | $227.82K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 23,411 | 0.31% | $102.31K | 0.01% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 10,332 | 0.14% | $60.13K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 9,966 | 0.13% | $58.00K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 2,849 | 0.04% | $16.58K | 0.00% | May 31, 2026 |
| 1290 VT Micro Cap Portfolio | 1,518 | 0.02% | $6.63K | 0.00% | Jun 30, 2026 |
| Total Stock Market Index Trust | 135 | 0.00% | $590 | 0.00% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 20 | 0.00% | $87 | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ronald Asbury Andrews | Chief Business Officer, Director | 1,843 | 0.02% | Nov 12, 2026 |
| Marc H. Hedrick | Chief Executive Officer, Director | 105,714 | 1.39% | Oct 1, 2026 |
| Andrew John Hugh MacIntyre Sims | Chief Financial Officer | 12,926 | 0.17% | Oct 1, 2026 |
| Eric Joseph Daniels | Chief Development Officer | 0 | – | Apr 22, 2026 |
| Howard Clowes | Director | 2,902 | 0.04% | Oct 1, 2026 |
| Kyle Guse | Director | 1,843 | 0.02% | Oct 1, 2026 |
| Richard J. Hawkins | Director | 2,450 | 0.03% | Oct 1, 2026 |
| Es-Johansson An van | Director | 1,843 | 0.02% | Oct 1, 2026 |
| Robert P. Lenk | Director | 139,327 | 1.84% | Aug 25, 2025 |
| Greg Petersen | Director | 48,921 | 0.64% | Feb 20, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Ronald Asbury Andrews Director | Oct 1, 2026 | Option exercise | +921 | – | – | 1,843 |
| Howard Clowes Director | Oct 1, 2026 | Option exercise | +921 | – | – | 2,902 |
| Es-Johansson An van Director | Oct 1, 2026 | Option exercise | +921 | – | – | 1,843 |
| Richard J. Hawkins Director | Oct 1, 2026 | Option exercise | +921 | – | – | 2,450 |
| Andrew John Hugh MacIntyre Sims Chief Financial Officer | Oct 1, 2026 | Option exercise | +287 | – | – | 12,926 |
| Andrew John Hugh MacIntyre Sims Chief Financial Officer | Oct 1, 2026 | Option exercise | +1,165 | – | – | 12,639 |
| Andrew John Hugh MacIntyre Sims Chief Financial Officer | Oct 1, 2026 | Option exercise | +1,533 | – | – | 11,474 |
| Marc H. Hedrick Chief Executive Officer, Director | Oct 1, 2026 | Option exercise | +1,986 | – | – | 60,922 |
| Marc H. Hedrick Chief Executive Officer, Director | Oct 1, 2026 | Option exercise | +8,066 | – | – | 58,936 |
| Marc H. Hedrick Chief Executive Officer, Director | Oct 1, 2026 | Option exercise | +6,387 | – | – | 50,870 |
| Kyle Guse Director | Oct 1, 2026 | Option exercise | +921 | – | – | 1,843 |
| Marc H. Hedrick Chief Executive Officer, Director | Jul 1, 2026 | Option exercise | +1,986 | – | – | 44,483 |
| Marc H. Hedrick Chief Executive Officer, Director | Jul 1, 2026 | Option exercise | +6,387 | – | – | 34,431 |
| Marc H. Hedrick Chief Executive Officer, Director | Jul 1, 2026 | Option exercise | +8,066 | – | – | 42,497 |
| Ronald Asbury Andrews Director | Jul 1, 2026 | Option exercise | +922 | – | – | 922 |
| Howard Clowes Director | Jul 1, 2026 | Option exercise | +922 | – | – | 1,981 |
| Andrew John Hugh MacIntyre Sims Chief Financial Officer | Jul 1, 2026 | Option exercise | +1,533 | – | – | 8,489 |
| Andrew John Hugh MacIntyre Sims Chief Financial Officer | Jul 1, 2026 | Option exercise | +287 | – | – | 9,941 |
| Andrew John Hugh MacIntyre Sims Chief Financial Officer | Jul 1, 2026 | Option exercise | +1,165 | – | – | 9,654 |
| Kyle Guse Director | Jul 1, 2026 | Option exercise | +922 | – | – | 922 |
| Richard J. Hawkins Director | Jul 1, 2026 | Option exercise | +922 | – | – | 1,529 |
| Es-Johansson An van Director | Jul 1, 2026 | Option exercise | +922 | – | – | 922 |
| Marc H. Hedrick Chief Executive Officer, Director | Apr 1, 2026 | Option exercise | +159,681 | – | – | 499,468 |
| Marc H. Hedrick Chief Executive Officer, Director | Apr 1, 2026 | Option exercise | −201,632 | – | – | 701,100 |
| Andrew John Hugh MacIntyre Sims Chief Financial Officer | Apr 1, 2026 | Option exercise | +29,129 | – | – | 173,913 |
| Andrew John Hugh MacIntyre Sims Chief Financial Officer | Apr 1, 2026 | Option exercise | +38,323 | – | – | 144,784 |
| Andrew John Hugh MacIntyre Sims Chief Financial Officer | Jan 1, 2026 | Option exercise | +38,323 | – | – | 106,461 |
| Marc H. Hedrick Chief Executive Officer, Director | Jan 1, 2026 | Option exercise | +159,681 | – | – | 339,787 |
| Andrew John Hugh MacIntyre Sims Chief Financial Officer | Nov 4, 2025 | Buy | +20,000 | $0.51 | $10.20K | 68,138 |
| Marc H. Hedrick Chief Executive Officer, Director | Oct 1, 2025 | Option exercise | +159,681 | – | – | 180,106 |
| Andrew John Hugh MacIntyre Sims Chief Financial Officer | Oct 1, 2025 | Option exercise | +38,323 | – | – | 48,138 |
| Robert P. Lenk Director | Aug 22, 2025 | Buy | +110,000 | $0.49 | $53.90K | 139,327 |
| Richard J. Hawkins Director | Sep 13, 2024 | Buy | +4,000 | $1.50 | $6.00K | 15,188 |
| Richard J. Hawkins Director | Sep 12, 2024 | Buy | +6,285 | $1.35 | $8.48K | 11,188 |
| Howard Clowes Director | Sep 11, 2024 | Buy | +5,000 | $1.34 | $6.70K | 26,497 |
| Greg Petersen Director | Sep 11, 2024 | Buy | +12,500 | $1.35 | $16.88K | 48,921 |
| Andrew John Hugh MacIntyre Sims Chief Financial Officer | Sep 10, 2024 | Buy | +4,098 | $1.27 | $5.20K | 9,815 |
| Marc H. Hedrick Chief Executive Officer, Director | Sep 10, 2024 | Buy | +8,000 | $1.23 | $9.84K | 20,425 |
| Robert P. Lenk Director | May 8, 2024 | Buy | +4,167 | $2.04 | $8.50K | 29,327 |
| Andrew John Hugh MacIntyre Sims Chief Financial Officer | May 8, 2024 | Buy | +4,902 | $2.04 | $10.00K | 5,717 |
| Howard Clowes Director | May 8, 2024 | Buy | +9,804 | $2.04 | $20.00K | 21,497 |
| Greg Petersen Director | May 8, 2024 | Buy | +12,255 | $2.04 | $25.00K | 36,421 |
| Marc H. Hedrick Chief Executive Officer, Director | May 8, 2024 | Buy | +12,255 | $2.04 | $25.00K | 12,425 |
| Richard J. Hawkins Director | May 8, 2024 | Buy | +4,902 | $2.04 | $10.00K | 4,903 |
| Marc H. Hedrick Chief Executive Officer, Director | Nov 20, 2023 | Sale | −2,068 | $1.96 | $4.05K | 170 |
| Robert P. Lenk Director | Nov 16, 2023 | Buy | +1,000 | $1.95 | $1.95K | 25,160 |
| Robert P. Lenk Director | Nov 15, 2023 | Buy | +1,000 | $1.77 | $1.77K | 24,160 |
| Robert P. Lenk Director | Nov 13, 2023 | Buy | +4,000 | $1.43 | $5.72K | 23,160 |
| Robert P. Lenk Director | Nov 10, 2023 | Buy | +2,000 | $1.45 | $2.90K | 19,160 |
| Robert P. Lenk Director | Nov 9, 2023 | Buy | +4,199 | $1.59 | $6.68K | 17,160 |
| Robert P. Lenk Director | Nov 8, 2023 | Buy | +5,000 | $1.65 | $8.25K | 12,961 |
| Robert P. Lenk Director | Nov 7, 2023 | Buy | +6,000 | $1.64 | $9.84K | 7,961 |
| Robert P. Lenk Director | Nov 6, 2023 | Buy | +1,395 | $1.50 | $2.09K | 1,961 |
| Howard Clowes Director | Sep 13, 2023 | Buy | +6,993 | $1.43 | $10.00K | 11,693 |
| Greg Petersen Director | Sep 11, 2023 | Buy | +20,000 | $1.70 | $34.00K | 24,166 |
| Howard Clowes Director | Jun 6, 2023 | Buy | +1,000 | $3.98 | $3.98K | 4,700 |
| Howard Clowes Director | May 3, 2023 | Buy | +2,500 | $3.64 | $9.10K | 3,700 |
| Richard J. Hawkins Director | Mar 3, 2023 | Buy | +1 | $1000.00 | $1.00K | 1 |
| Robert P. Lenk Director | Dec 30, 2022 | Sale | −1,500 | $0.31 | $465 | 8,500 |
| Marc H. Hedrick Chief Executive Officer, Director | Jun 15, 2022 | Buy | +5,000 | $0.65 | $3.25K | 33,580 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 3 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Cerenome's stock actually held short. Settlement fails (shares not delivered on time) peaked at 29,577 shares on Oct 5, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Greg Petersen Director | May 7, 2025 | 36,666 | $20.28K | May 15, 2025 | Market Buy |
See a number that looks wrong?